



















NUAK1 and senescence  
 
The AMP-activated protein kinase-related kinase 
(ARK) family comprises 13 proteins, amongst them 
NUAK1, that can be classified into five subfamilies: 
AMP-activated protein kinase (AMPK), salt-induced 
kinase (SIK), microtubule-affinity-regulating kinase 
(MARK), brain specific kinase (BRSK), and SNF1-like 
kinase 1 (NUAK). These proteins regulate biological 
responses such as metabolism, polarity, cell 
proliferation or cell death, presumably in a sub-family 
specific manner [1]. Although the different proteins 
regulate different responses, their activities are thought 
to be controlled by the same kinase, LKB1 [2], which 
phosphorylates a threonine residue in the conserved T-
loop of ARK proteins. AMPK proteins are 
phosphorylated and activated by LKB1 when ATP 
levels decrease, whereas ARK proteins are phosphory-
lated and activated independently of intracellular ATP 
levels [1]. 
 
During metabolic stress, ATP levels decrease and LKB1 
activates AMPK that, in turn, phosphorylates a subset of 
proteins. P53 has been identified as one of these 
proteins, and it is postulated that the phosphorylation 
and activation of p53 by AMPK leads to cell cycle 
arrest and senescence [3]. 
 
We have recently identified and described the role of 
NUAK1 in the regulation of replicative senescence. 
Indeed, the constitutive expression of NUAK1 induces 
senescence in WI38 normal human fibroblasts whereas 
its knockdown extends their replicative lifespan. The 
loss of  NUAK1 activation by LKB1 (by using a  NUAK1 
 
 


















NUAK1 mutant unresponsive to LKB1 or by inhibiting 
LKB1 activity in NUAK1 expressing cells) results in a 
failure of NUAK1 to induce senescence, thus 
demonstrating the major role of LKB1 in NUAK1-
induced senescence. Interestingly, our results support 
the existence of a p53 independent response, at least in 
WI38 cells, and emphasize a potential role of 
aneuploidy in NUAK1-dependent senescence [4]. 
 
Aneuploidy and senescence 
 
Aneuploidy or genomic instability due to various 
factors have been reported to induce senescence [5,6,7]. 
Interestingly, senescent cells often display elevated 
aneuploidy, which suggests a putative functional role of 
aneuploidy in senescence. Nevertheless, it is unclear 
whether aneuploidy is involved in the establishment of 
the senescent phenotype and, if prevented, it can impair 
senescence, at least to some extent. A breakthrough has 
been achieved with the demonstration that the state of 
irreversible growth arrest in senescent cells may be due 
to elevated aneuploidy, putatively through a decrease of 
LATS1, a kinase involved in mitotic exit [7]. These 
results suggest that aneuploidy, if not directly involved 
in the establishment of senescence, can be required for 
irreversible growth arrest in senescent cells. 
 
Interestingly, aneuploidy was also observed during 
replicative senescence and during NUAK1-induced 
premature senescence in our model. More importantly, 
the replicative lifespan extension due to NUAK1 
knockdown correlated with normal ploidy. Altogether, 
these results suggest that ploidy can be a functional 
regulator of the senescence program. 
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NUAK1 and a putative regulator of ploidy in NUAK1-
dependent senescence. Altogether, these results suggest 
that aneuploidy could be part of the endogenous 
senescence program. Its mis-regulation could therefore 
induce premature senescence through a process that we 
chose to term "aneuploidy-induced senescence" (AIS). 
Our results also suggest that AIS may occur, at least in 
some settings, without the involvement of the p53 
pathway. Interestingly, others have described that the 
overexpression of Aurora A, a serine threonine kinase 
tightly associated with the mitotic process, induces 
senescence in the mammary gland of p53-deficient mice 
[8]. Hence aneuploidy could be one of the signals 
triggering senescence and could act, in some settings, 
independently of p53. 
 
Aneuploidy-induced senescence as a possible 
safeguard against tumor formation and development 
 
Oncogene activation is one of the hallmarks of cancer 
cells and a driving force in tumorigenesis [9]. 
Oncogene-induced senescence (OIS) was described 
about a decade ago [10], and a long debate has raged 
about its relevance. With the development of adequate 
mouse models of cancer susceptibility and new tools to 
detect senescence in vivo, it has become possible do 
demonstrate its effectiveness in blocking malignant 
transformation [11].  
 
Aneuploidy, another classical hallmark of cancer cells, 
is also believed to be involved in tumorigenesis [12]. As 
mentioned above, induction of aneuploidy can result in 
premature senescence in various settings [5,6,7]. 
Together, these observations suggest that AIS, like OIS, 
could constitute a failsafe mechanism against early 
tumorigenesis. To validate this hypothesis, it would be 
interesting to test the presence and the frequency of 
aneuploidy in benign lesions and to identify the genetic 
events possibly favoring AIS escape. 
 
The AIS model could resolve the apparent discrepancy 
about the role of NUAK1 in tumorigenesis. Our recent 
findings demonstrate an ability of NUAK1 to induce 
premature senescence in normal human cells whereas 
others, mainly the team of H. Esumi, have demonstrated 
a pro tumoral effect of NUAK1 through promoting cell 
growth and invasion [13,14,15]. However, these last 
conclusions were based on data obtained in cancer cell 
lines, in particular in colon cancer cell lines known to 
be highly aneuploid [16]. Thus, NUAK1 may have no 
additional effect on genomic stability and instead 
regulate other targets to confer a growth advantage to 
the cells. NUAK1 might even add more genomic 
instability, thus conferring additional growth and 
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